cytomegalovirus

(redirected from Cytomegalovirus infection)
Also found in: Thesaurus, Medical, Encyclopedia.

cy·to·meg·a·lo·vi·rus

 (sī′tə-mĕg′ə-lō-vī′rəs)
n. Abbr. CMV
Any of a group of herpesviruses that attack and enlarge epithelial cells. Such viruses also cause a disease of infants characterized by circulatory dysfunction and microcephaly.

cytomegalovirus

(ˌsaɪtəʊˈmɛɡələʊˌvaɪrəs)
n
(Microbiology) a virus of the herpes virus family that may cause serious disease in patients whose immune systems are compromised. Abbreviation: CMV

cy•to•meg•a•lo•vi•rus

(ˌsaɪ toʊˌmɛg ə loʊˈvaɪ rəs)

n., pl. -rus•es.
a herpesvirus that produces abnormal enlargement of epithelial cells, usu. mildly infectious but a cause of pneumonia in immunodeficient persons and severe systemic damage in the newborn.
[1960–65]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.cytomegalovirus - any of a group of herpes viruses that enlarge epithelial cells and can cause birth defects; can affect humans with impaired immunological systems
herpes virus, herpes - any of the animal viruses that cause painful blisters on the skin
Translations

cy·to·meg·a·lo·vi·rus

n. citomegalovirus, grupo de virus pertenecientes a la familia Herpesviridae que infectan humanos y otros animales, y son causantes de la enfermedad de inclusión citomegálica.

cytomegalovirus (CMV)

n citomegalovirus m (CMV)
References in periodicals archive ?
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products.
M2 PHARMA-November 10, 2017-US FDA Approves US Merck's Prevymis for Prevention of Cytomegalovirus Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients
Rare presentations of cytomegalovirus infection in renal allograft recipients.
Socio-demographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey.
Objectives: We aimed to study viral replication and serological response in the first months post kidney transplant in patients undergoing universal prophylaxis or preemptive therapy and correlate the findings with the clinical course of Human cytomegalovirus infection.
Goedhals D, Krielb J, Hertzogc ML, Janse van Rensburg MN (2008) Human cytomegalovirus infection in infants with prolonged neonatal jaundice.
United States-based Merck has met its primary endpoint in a phase three clinical trial evaluating the company's letermovir, intended for the prevention of cytomegalovirus infection in high-risk bone marrow transplant patients, it was reported yesterday.
Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection.
Cellular immunity and active human Cytomegalovirus infection in patients with septic shock.
Meylan, "Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir," Transplantation Proceedings, vol.
Cytomegalovirus infection and schizencephaly: Case report.